Thursday, November 7 - Friday, November 8, 2019 | Renaissance Washington, D.C.
THE ONLY COMMERCIALLY FOCUSED AMR CONFERENCE GLOBALLY
FOR PHARMA & BIOTECH, PAYERS, REGULATORS AND THEIR PARTNERS
WHAT IS THE
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS?
Networking
It’s not just about the conference sessions, our Congress recognises the importance of networking.
With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
Conference
The World Anti-Microbial Resisitance Congress brings together all the stakeholders involved in developing new antimicrobial drugs and diagnostics.
The event focusses on one of the most important challenges currently facing the global healthcare sector: tackling scientific and economic issues around antimicrobial resistance.
Exhibition
This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.
Sponsorship packages are tailored to meet your specific marketing goals. So don’t delay, contact us now to se how we can help your business.
HALL OF FAME
Anti-Microbial Resistance Leaders Who Previously Spoke at the World AMR Congress
"Great opportunity to network, and hear the perspectives of CEOs, FDA and other key health leaders on issues related to antimicrobial resistance"
Debra Goff,Infectious Diseases Specialist,The Ohio State University Wexner Medical Center
WHO ATTENDS?
Accele Biopharma Accelerate Diagnostics Achaogen Actavis Actelion Clinical Research, Inc. adtec europe Ltd Aeras Aetna Pharmacy Management Agile Sciences, Inc. Alliance for Aging Research American Society for Microbiology Amplyx Pharmaceuticals, Inc Antibiotic Adjuvant, Inc Antibiotics - The Perfect Storm Arsanis Inc Asepticys Astellas Pharma U.S. AstraZeneca Auspherix Ltd BARDA Basilea Pharmaceutica Ltd Baylor College of Medicine Becton Dickinson Biofilm Control BioFire Defense Bio-Manguinhos/Fiocruz Biomerieux, Inc Boston University School of Law Boulos & Cooper C.U.B.R.C. Inc CARB-X Catholic University of Brasilia CDC CDRH OIR FDA Cempra Cempra, Inc. Center for Disease Control & Prevention Center for Infectious Disease Research and Policy (CIDRAP) Center for Scientific Review/NIH Cepheid Cidara Therapeutics College of Staten Island Community for Open Antimicrobial Drug Discovery Contrafect Corporation CorMedix Inc COVANCE INC. Crestone Inc Curza D.S.M. Sinochem Pharmaceuticals Danish Broadcasting Corp Department of Health and Human Services Diversigen DSM Sinochem Pharmaceuticals Duke University Emergent BioSolutions Inc Entasis Therapeutics EpiBiome European Commission Evotec F. Hoffmann-La Roche Ltd FDA Forge Therapeutics Fox Therapeutics George Mason University, College of Science George Washington University School of Medicine & Health Sciences GSK Harvard University HHS/BARDA Howard University Hospital IMMT Independent Consultant InnoTune BVBA Innovative Medicines Initiative Institute for Life Science Entrepreneurship, Kean University Intralytix Inc. Istituti Fisioterapici Ospitalieri Iterum Therapeutics Ivogen Janssen Pharmaceuticlas Ltd JMI Laboratories Lakewood-Amedex Inc. Lund University Massachusetts General Hospital Massachusetts Institute of Technology Mayo Clinic McMaster University MedImmune Inc MedStar Union Memorial Hospital Meiji Seika Pharma Co., Ltd. Merck & Co. Mericopia Integrated Healt System Motif BioSciences, Inc. MRIGlobal Nabriva Therapeutics National Institutes of Health Natural MA Nesta NIH - NIAID Northeastern University Novan Therpeutics Ohio Northern University OpGen Inc PAHO/WHO Paratek Pennsylvania State University Pew Charitable Trusts Pfizer Phagelux Physician Resources Politico Polypharmakos Limited PSI PSI CRO Public Health Agency of Canada Public Health England PureTech Health Raleigh Fitkin Memorial Hospital Reagan Udall Foundation for the F.D.A. Review on Antimicrobial Resistance Rho Roche Innovation Center New York S.R. One Sample6 Sandoz Sanofi Science Speaks Blog Scynexis, Inc. Self Shionogi Inc Spero Therapeutics State University of New York at Buffalo Stevens Institute of Technology SymbalRx Telephus Medical Llc Tetraphase Pharmaceuticals Teva The Conafay Group The Medicines Company The Pew Charitable Trusts Tiber Creek Partners Touro University Nevada U.S. Department of Health & Human Services UCLA David Geffen School of Medicine UMSL United States Department of Health & Human Services UnityPoint Health-Meriter Hospital University Hospital, Lyon University of California Merced University of California San Francisco University of Cambridge University of Maryland University College University of Missouri-St. Louis University of Rochester Medical Center University of Utah School of Medicine University of Warwick ppsala University Vanderbilt University VenatoRx Pharmaceuticals Inc Viamet Pharmaceuticals Vivexia Wellcome Trust Zeus capital
A UNIQUE OPPORTUNITY
Established brands use our events to consolidate their position, grow market share, or enter new sectors or territories. Challenger brands use our events to demonstrate thought leadership, establish their point of difference, and win over new customers. Join us!
GET INVOLVED AT
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS
Sign Up for Event Updates
Organiser
